Skip to content

The Effects of Using an Interactive Game With Virtual Reality for Children During Intravenous Placement

The Effects of Using an Interactive Game With Virtual Reality to Reduce the Pain and Fear for Children During an Intravenous Placement

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04558086
Enrollment
134
Registered
2020-09-22
Start date
2020-06-05
Completion date
2020-09-11
Last updated
2020-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fear, Pian

Keywords

Therapeutic play,virtual reality, intravenous placement, school-age, pain, fear

Brief summary

To develop the intervention strategies of hospitalized school-age children with IV placement, using interactive virtual reality(VR)as a guiding play and emotional catharsis play, to further examine the effectiveness of reducing IV pain and fear.

Interventions

DEVICEVirtual reality

To develop the intervention strategies of hospitalized school-age children with IV placement, using interactive virtual reality(VR)as a guiding play and emotional catharsis play, to further examine the effectiveness of reducing IV pain and fear.

DEVICEPhoto book

To develop the intervention strategies of hospitalized school-age children with IV placement, using Photo book to further examine the effectiveness of reducing IV pain and fear.

Sponsors

National Yang Ming Chiao Tung University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
6 Years to 12 Years
Healthy volunteers
No

Inclusion criteria

* Children ages 6-12. * Children who where clearly conscious. * Children who agreed and were required to receive intravenous injections after physicians' diagnoses. * Children and their primary caregivers who could communicate in Mandarin or Taiwanese * Children and their primary caregivers who could read Chinese that agreed to participate in this study and sign written consent forms

Exclusion criteria

* Children with developmental delay, epilepsy, or heart diseases * Children undergoing chemotherapy; children who were visually or hearing impaired * Children who were nearsighted with more than 8.0 diopters or farsighted with 5.0 diopters. * Children who had sustained head trauma in the past month * Children who were confirmed to be obese according to the recommended body mass index values for children and adolescents * Children who required blood transfusions and blood preparation to be performed according to physician diagnoses * Children who received two or more intravenous injections and had their blood drawn only one time

Design outcomes

Primary

MeasureTime frameDescription
The degrees of pain experienced by the children.The posttests 8 min after the tourniquets were worn.Measurement of pin using the Wong-Baker Faces Pain Rating Scale (WBFPS). The scale contains six cartoon faces shwing pain ratings of 0\ 10, which are, from left to right, no pain(0), a little pain (2), mild pain (4), average pain (6), severe pain (8), and excruciating pain (10).The children, primary caregivers, and nurses were asked to select the faces that best described the pain levels experienced by the children receiving intravenous injections; the pain levels were subsequently converted into numerical values .
The degrees of fear experienced by the children.The posttests 8 min after the tourniquets were worn.Measurement of fear using the Choldren Fear Scale(CFS).The scale consists of five cartoon faces showing fear ratings of 0-4, which were no fear (0), a little fear (1), some fear (2), very fear(3) and extreme fear (4). The children, primary caregivers, and nurses were asked to select the faces that best described the fear levels of the children receiving intravenous injections. The pain levels were subsequently converted into numerical values.

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026